Cargando…
miR-34a/DRP-1-mediated mitophagy participated in cisplatin-induced ototoxicity via increasing oxidative stress
PURPOSE: Cisplatin is a widely used and effective chemotherapeutic agent for most solid malignant tumors. However, cisplatin-induced ototoxicity is a common adverse effect that limits the therapeutic efficacy of tumors in the clinic. To date, the specific mechanism of ototoxicity has not been fully...
Autores principales: | Wang, Haiyan, Lin, Hanqing, Kang, Weibiao, Huang, Lingfei, Gong, Sisi, Zhang, Tao, Huang, Xiaotong, He, Feinan, Ye, Yongyi, Tang, Yiyang, Jia, Haiying, Yang, Haidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993635/ https://www.ncbi.nlm.nih.gov/pubmed/36882858 http://dx.doi.org/10.1186/s40360-023-00654-1 |
Ejemplares similares
-
Regulation of ACSL4-Catalyzed Lipid Peroxidation Process Resists Cisplatin Ototoxicity
por: He, Feinan, et al.
Publicado: (2022) -
Mitophagy Impairment Aggravates Cisplatin-Induced Ototoxicity
por: Cho, Sung Il, et al.
Publicado: (2021) -
Mitophagy in ototoxicity
por: Han, Hezhou, et al.
Publicado: (2023) -
Cisplatin ototoxicity histopathology
por: Hodge, Sarah E., et al.
Publicado: (2021) -
Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function
por: Zhao, Chuanyan, et al.
Publicado: (2017)